cGAS-STING Cytosolic DNA Sensing Pathway
The cGAS-STING pathway is an essential innate immune surveillance mechanism that detects foreign or mislocalized cytosolic DNA, synthesizing the cyclic dinucleotide 2'3'-cGAMP to trigger type I interferon production.
cGAS-STING cytosolic DNA sensing pathway is a fundamental intracellular innate immune mechanism that monitors the eukaryotic cytoplasm for the aberrant presence of double-stranded DNA (dsDNA). Under healthy physiological conditions, host genomic DNA is sequestered within the cell nucleus, and mitochondrial DNA is confined within intact mitochondrial membranes. When viral infection, bacterial invasion, cellular senescence, or nuclear envelope rupture introduces dsDNA into the cytosol, the nucleotidyltransferase enzyme cyclic GMP-AMP synthase (cGAS) binds the misplaced DNA in a sequence-independent manner.
Discovered by Zhijian "James" Chen and colleagues in 2013, cGAS catalyzes the synthesis of a non-canonical cyclic dinucleotide second messenger, 2'3'-cGAMP, from ATP and GTP. The diffusible second messenger binds and activates the adaptor protein STING (stimulator of interferon genes), located in the endoplasmic reticulum membrane. STING translocates to the Golgi apparatus, recruiting TANK-binding kinase 1 (TBK1) and the transcription factor IRF3 to drive robust transcription of type I interferons (IFN-alpha, IFN-beta) and pro-inflammatory cytokines, coordinating antimicrobial defenses and anti-tumor immunity.
Structural Mechanism of cGAS Activation and cGAMP Synthesis
cGAS functions as a structural ruler that senses DNA length. In the absence of DNA, cGAS exists in an autoinhibited, enzymatically dormant conformation in the cytosol and cell periphery.
Binding requires double-stranded DNA exceeding 45 base pairs in length. Basic positively charged surface patches on cGAS interact with the negatively charged sugar-phosphate backbone of the DNA minor groove, independent of the specific nucleotide sequence. This binding induces liquid-liquid phase separation, condensing cGAS and dsDNA into membraneless liquid droplets that concentrate enzymatic reactants while excluding negative regulatory phosphatases.
Enzymatic Condensation and 2'3'-cGAMP Synthesis
Within these liquid condensates, cGAS forms a 2:2 dimeric complex with DNA, restructuring the enzyme's catalytic pocket. The activated active site condenses one molecule of adenosine triphosphate (ATP) and one molecule of guanosine triphosphate (GTP) through a two-step phosphodiester linkage reaction. The product is 2'3'-cyclic GMP-AMP (2'3'-cGAMP), an unusual cyclic dinucleotide possessing one canonical 3'-5' phosphodiester bond and one non-canonical 2'-5' phosphodiester bond, which confers high resistance to degradation by host phosphodiesterases.
STING Activation, Trafficking, and Kinase Recruitment
The newly synthesized 2'3'-cGAMP second messenger diffuses rapidly through the cytoplasm to bind STING, a dimeric transmembrane protein anchored in the endoplasmic reticulum (ER) membrane, first characterized by Glen Barber and colleagues in 2008.
Binding of 2'3'-cGAMP inside the central ligand-binding pocket of the STING cytoplasmic domain causes a 180-degree rotational shift in the protomers. A flexible lid region closes over the bound dinucleotide, inducing the polymerisation of STING dimers into side-by-side linear oligomers.
Conformational closure exposes an export signal that packages STING oligomers into COP-II vesicles, mediating retrograde transport from the ER through the ER-Golgi intermediate compartment (ERGIC) to the perinuclear Golgi apparatus. At the Golgi, the clustered C-terminal tails of STING recruit TANK-binding kinase 1 (TBK1). TBK1 trans-autophosphorylates and subsequently phosphorylates a conserved serine residue on the adjacent STING tail, creating a high-affinity docking site for interferon regulatory factor 3 (IRF3). TBK1 then phosphorylates IRF3, causing it to dimerize, dissociate from the Golgi, and translocate into the nucleus to drive the transcription of IFNB1 and interferon-stimulated genes (ISGs). Concurrently, STING activates I-kappa-B kinase (IKK), liberating NF-kappa-B to induce pro-inflammatory cytokine expression (IL-6, TNF).
Host Defense, Retroviral Surveillance, and Pathogen Evasion
The cGAS-STING axis serves as an essential frontline sentinel against DNA viruses (such as herpes simplex virus 1, cytomegalovirus, and vaccinia virus) and intracellular bacteria (such as Listeria monocytogenes and Mycobacterium tuberculosis).
During retroviral infections, such as human immunodeficiency virus 1 (HIV-1), reverse transcription of the viral RNA genome produces complementary cDNA in the cytoplasm. In 2013, Daxing Gao and colleagues demonstrated that cGAS detects these early reverse transcripts, triggering interferon responses that restrict viral replication.
To survive within the host, pathogenic viruses have evolved specialized virulence factors that dismantle the cGAS-STING pathway:
- Dengue and Zika Viruses: Cleave human STING via viral NS2B3 serine proteases.
- Adenoviruses: Inactivate cGAS through the oncoprotein E1A.
- Herpesviruses: Encode viral deubiquitinases and nucleases (such as HSV-1 UL37 and UL36) that deamidate cGAS or degrade 2'3'-cGAMP before STING activation can occur.
Autoimmunity and Tumor Immunology
Dysregulated activation of the cGAS-STING pathway drives severe autoimmune and autoinflammatory diseases. In Aicardi-Goutiรจres syndrome (AGS), loss-of-function mutations in the cytosolic 3'-5' DNA exonuclease TREX1 allow endogenous retroelements and replication debris to accumulate in the cytoplasm, triggering chronic, lethal type I interferon production that causes neuro-inflammation and chilblain lupus. Similarly, mutations in STING causing constitutive ligand-independent activation result in SAVI (STING-associated vasculopathy with onset in infancy), characterized by severe systemic inflammation, skin ulceration, and interstitial lung disease.
Conversely, in oncology, cGAS-STING activation is critical for anti-tumor immunity. Chromosomal instability, defective DNA repair, and radiation therapy cause micronuclei to rupture in malignant cells, exposing genomic DNA to cytoplasmic cGAS. The resulting 2'3'-cGAMP production stimulates cross-presenting dendritic cells, promoting cytotoxic CD8+ T-cell infiltration into the tumor microenvironment. Consequently, synthetic STING agonists and cGAMP analogues represent major clinical candidates in combination immunotherapies alongside immune checkpoint inhibitors.
References
- Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013). Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science, 339(6121), 786โ791. doi:10.1126/science.1232458
- Gao, D., Wu, J., Wu, Y. T., Du, F., Aroh, C., Yan, N., Sun, L., & Chen, Z. J. (2013). Cyclic GMP-AMP synthase is required for innate immune activation by HIV, murine leukemia virus, and feline immunodeficiency virus. Cell Host & Microbe, 14(6), 693โ703. doi:10.1038/nature12779
- Ishikawa, H., & Barber, G. N. (2008). STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature, 455(7213), 674โ678. doi:10.1038/nature07202